Eric Vail

919 total citations · 1 hit paper
36 papers, 468 citations indexed

About

Eric Vail is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Eric Vail has authored 36 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Infectious Diseases. Recurrent topics in Eric Vail's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Eric Vail is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Eric Vail collaborates with scholars based in United States, Denmark and Philippines. Eric Vail's co-authors include Wenjuan Zhang, Brian Davis, Jasmine Plummer, Stephanie S. Chen, John T. Fallon, Guiqing Wang, Ximing J. Yang, Minghao Zhong, Esther Yoon and Xiaoyong Zheng and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Eric Vail

32 papers receiving 459 citations

Hit Papers

Emergence of a Novel SARS-CoV-2 Variant in Southern Calif... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Emergence of a Novel SARS-CoV-2 Variant in Southern California
    2021 220 citations Wenjuan Zhang, Jasmine Plummer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Vail United States 11 264 106 71 67 59 36 468
Michelle Klein Netherlands 9 458 1.7× 126 1.2× 33 0.5× 68 1.0× 108 1.8× 16 746
Steven M. Sperry United States 16 268 1.0× 111 1.0× 107 1.5× 254 3.8× 182 3.1× 23 848
Rohit Mistry United Kingdom 10 117 0.4× 66 0.6× 70 1.0× 59 0.9× 71 1.2× 35 347
Mengyan Zhu China 10 235 0.9× 112 1.1× 21 0.3× 16 0.2× 42 0.7× 20 422
Shu‐Li Yang Taiwan 12 97 0.4× 80 0.8× 24 0.3× 69 1.0× 58 1.0× 28 391
Dominik Nörz Germany 19 346 1.3× 295 2.8× 57 0.8× 58 0.9× 134 2.3× 46 806
María Cristina Navas Colombia 17 152 0.6× 124 1.2× 63 0.9× 60 0.9× 49 0.8× 66 777
Anne B. Warwick United States 12 146 0.6× 178 1.7× 147 2.1× 28 0.4× 54 0.9× 33 657
Guilhem Cros France 10 145 0.5× 64 0.6× 30 0.4× 27 0.4× 49 0.8× 16 392
Rosaria Arvia Italy 13 119 0.5× 76 0.7× 19 0.3× 23 0.3× 54 0.9× 26 354

Countries citing papers authored by Eric Vail

Since Specialization
Citations

This map shows the geographic impact of Eric Vail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Vail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Vail more than expected).

Fields of papers citing papers by Eric Vail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Vail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Vail. The network helps show where Eric Vail may publish in the future.

Co-authorship network of co-authors of Eric Vail

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Vail. A scholar is included among the top collaborators of Eric Vail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Vail. Eric Vail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsiao, Susan J., Destin Black, Kelly A. Devereaux, et al.. (2025). Recommendations for Clinical Molecular Laboratories for Detection of Homologous Recombination Deficiency in Cancer. Journal of Molecular Diagnostics. 27(8). 685–704. 1 indexed citations
2.
Pendergast, Felicity J., Wenjuan Zhang, Eric Vail, et al.. (2025). Early cardio-oncology intervention in thoracic radiotherapy: prospective single-arm pilot study. Communications Medicine. 5(1). 43–43.
3.
4.
Smoller, Bruce R., et al.. (2023). Two distinct pathogenic pathways of digital papillary adenocarcinoma — BRAF mutation or low‐risk HPV infection. Journal of Cutaneous Pathology. 50(6). 568–576. 8 indexed citations
5.
Vail, Eric, Horacio Maluf, Mingtian Che, et al.. (2023). Gene Expression Profiling of Fibroepithelial Lesions of the Breast. International Journal of Molecular Sciences. 24(10). 9041–9041. 7 indexed citations
6.
Waters, Kevin, Wenjuan Zhang, Eric Vail, et al.. (2023). Molecular characterization of visible low-grade dysplastic lesions in patients with inflammatory bowel disease. Human Pathology. 135. 108–116. 1 indexed citations
7.
8.
Khan, Jaffar M., Asad Ullah, Siamak M. Seraj, et al.. (2022). Gastrointestinal Stromal Tumors (GIST): A Population-Based Study Using the SEER Database, including Management and Recent Advances in Targeted Therapy. Cancers. 14(15). 3689–3689. 21 indexed citations
9.
Shibata, Tomohiro, Duo‐Yao Cao, Faizan Ahmed, et al.. (2022). miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC. Cancers. 14(21). 5273–5273. 8 indexed citations
10.
Ullah, Asad, et al.. (2022). PD-L1 Over-Expression Varies in Different Subtypes of Lung Cancer: Will This Affect Future Therapies?. SHILAP Revista de lepidopterología. 12(5). 653–671. 15 indexed citations
11.
Vail, Eric, et al.. (2022). KMT2A-CBL fusion in rapidly progressive myeloid disorder. Cancer Genetics. 266-267. 90–92. 2 indexed citations
12.
Cox, Brian, et al.. (2021). Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinoma. SHILAP Revista de lepidopterología. 8(4). HEP39–HEP39. 14 indexed citations
13.
14.
Stampfer, Samuel D., Sean Bujarski, Wenjuan Zhang, et al.. (2021). Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination. Clinical Infection in Practice. 13. 100130–100130. 10 indexed citations
15.
Vail, Eric, Jianbo Song, Jing Xu, et al.. (2020). Comparison of Large, Medium, and Small Solid Tumor Gene Panels for Detection of Clinically Actionable Mutations in Cancer. Targeted Oncology. 15(4). 523–530. 9 indexed citations
16.
Kim, Jong, et al.. (2020). Three Primary Tumors Including EGFR-mutated Non–Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni Syndrome. Clinical Lung Cancer. 22(1). e116–e121. 1 indexed citations
17.
Wang, Arthur, et al.. (2017). Spinal Cord Compression Secondary to Metastatic Sinonasal Undifferentiated Carcinoma. Case Reports in Oncology. 10(2). 596–604. 3 indexed citations
18.
Huang, Weihua, Guiqing Wang, Henry C. Lin, et al.. (2016). Assessing next-generation sequencing and 4 bioinformatics tools for detection of Enterovirus D68 and other respiratory viruses in clinical samples. Diagnostic Microbiology and Infectious Disease. 85(1). 26–29. 6 indexed citations
19.
Vail, Eric, Xiaoyong Zheng, Ming Zhou, et al.. (2015). Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder. Annals of Diagnostic Pathology. 19(5). 301–305. 32 indexed citations
20.
Yoon, Esther, Eric Vail, George Kleinman, et al.. (2015). Lyme disease: a case report of a 17-year-old male with fatal Lyme carditis. Cardiovascular Pathology. 24(5). 317–321. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle Klein Breakdown of academic impact, for papers by Steven M. Sperry Breakdown of academic impact, for papers by Rohit Mistry Breakdown of academic impact, for papers by Mengyan Zhu Breakdown of academic impact, for papers by Shu‐Li Yang Breakdown of academic impact, for papers by Dominik Nörz Breakdown of academic impact, for papers by María Cristina Navas Breakdown of academic impact, for papers by Anne B. Warwick Breakdown of academic impact, for papers by Guilhem Cros Breakdown of academic impact, for papers by Rosaria Arvia
Rankless by CCL
2026